Published in
Taylor & Francis, Expert Opinion on Drug Safety, 9(18), p. 803-815, 2019
DOI: 10.1080/14740338.2019.1643838
Links
Tools
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
Journal article published in 2019 by
Ciro Costagliola,
Francesco Morescalchi,
Sarah Duse,
Davide Romano,
Giuseppina Mazza,
Francesco Parmeggiani,
Silvia Bartollino 
,
Francesco Semeraro
,
Francesco Semeraro
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 